miRNAの世界市場(~2020)

RNCOSが発行した調査報告書(RNCS51102)
◆英語タイトル:Global miRNA Market Outlook to 2020
◆商品コード:RNCS51102
◆発行会社(リサーチ会社):RNCOS
◆発行日:2015年10月
◆ページ数:130
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様利用)USD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Multi-UserUSD2,200 ⇒換算¥248,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はRNCOS社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。RNCOS社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、miRNAの世界市場について調査・分析し、miRNA技術、miRNAの用途別分析、miRNAのエンドユーザー別分析、miRNAの地域別分析、市場ドライバー、課題、市場機会、市場動向、市場規模、競争環境、関連企業分析などの情報をお届けいたします。
【レポートの概要】

miRNAs have risen as powerful regulators of different cellular processes with specifically important roles in disease and tissue remodelling. The miRNA is widely used in researches for identifying new application areas of its use. With respect to this, there are various clinical trials being organized throughout the world so as to evaluate the therapeutic potential of miRNA in curing various chronic diseases such as cancer, cardiovascular diseases, hepatic disorders, neurological disorders, and so forth. The report, Global miRNA Market Outlook to 2020, provides an overview of the current state of the miRNA market, focusing mainly on continuing research endeavors, emerging tools, reagents, techniques, diagnostics, and therapeutic products. Forecast projections are provided for the period, 2015 to 2020.

Brief information about the two major segmentation of miRNA market, i.e., tools and services, have been provided in the report. The former consists of different tools that are utilized to study miRNA including PCR arrays, labels, isolation kits, mimics, inhibitors, and markers. On the other hand, the latter includes various services such as purification, expression profiling, quantification, and analysis that are offered by miRNA players.

Based on diseases in which miRNA tools are used, the report provides insights about cancer, cardiovascular diseases, hepatic disorders, neurological disorders, and other diseases. The report provides the current as well as the forecasted market for miRNA use in each of diseases.

The report also segments the market based on the end users of these miRNA tools and services. The end users of the miRNA tools and services include research labs and institutes, biotechnology and biopharmaceutical industries, and hospitals and diagnostic centers. Detailed information regarding the current market size and the year-on-year forecasted markets is provided for each end user.

Based on geography, the miRNA market has been categorized into three segments: The Americas, Europe, and Asia Pacific. These regions have then been investigated for analyzing the current research and industrial applications of miRNAs. An in-depth analysis of the market recommends that cancer is the most researched subject out of neurodegenerative, cardiovascular, hepatic, and other chronic diseases. United States, France, Germany, United Kingdom, China, Israel, and Korea are the significant players interested in assessing the potential of miRNA.

The miRNA tools and services find major application in research area. Other major application areas of miRNA include diagnostics and drug development. The report provides the share of each application for 2014.

The major players in the miRNA market include Qiagen (Germany), Sigma-Aldrich Corporation (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies Inc. (US), Affymetrix, (US), Integrated DNA Technologies (US), Exiqon (Denmark), Mirus Bio LLC (US), Wako Pure Chemical Industries (Japan), and Rosetta Genomics Ltd. (Israel). These players are working over a wide range of products including miRNA extraction and purification kits, and miRNA mimics and inhibitors, and are consistently redesigning & updating their portfolio to stay connected and updated with the most recent advancements in the field.

【レポートの目次】

1. Analyst View
2. Research Methodology
3. miRNA – An Introduction
4. miRNA Techniques
4.1 miRNA Purification
4.2 miRNA Labeling
4.3 miRNA Linear Amplification
4.4 miRNA Microarrays
4.5 miRNA qRT-PCR
4.6 miRNA Inhibition
4.7 miRNA Transfection
5. Industry Overview
5.1 Market Drivers
5.1.1 Growing Focus on Developing of miRNA-based Diagnostic Biomarkers
5.1.2 Technological Advancements
5.1.3 Rise in miRNA-based Researches
5.1.4 Increasing Prevalence of Chronic Diseases
5.1.5 Rising Investments in miRNA Market
5.2 Market Opportunities
5.2.1 Increasing miRNA-based Research in Cardiovascular Biology and Disease
5.2.2 Therapeutics Application Offers Significant Growth Opportunity
5.3 Market Challenges
5.3.1 High Cost of developing miRNA-based Tools
5.3.2 Technological Challenges in Developing miRNA-based Therapeutics
5.4 Market Trends
5.4.1 Increasing Strategic Alliances in the Market
5.4.2 Next Generation Sequencing: Gaining Momentum
6. Global miRNA Market Outlook to 2020
6.1 miRNA Tools and Services Market
7. Global miRNA Market by Applications
7.1 Research
7.2 Diagnostics
7.3 Drug Development
8. Global miRNA Market by End User
8.1 Research Labs and Institutes
8.2 Biotechnology Industry
8.3 Hospitals and Diagnostic Centers
9. Global miRNA Market by Geography
9.1 The Americas
9.2 Europe
9.3 Asia Pacific (APAC)
10. Global miRNA Market, by Disease
10.1 Introduction
10.2 Cancer
10.3 Neurological Diseases
10.4 Cardiovascular Diseases
10.5 Hepatic Diseases
10.6 Other Diseases
11. Portfolio of miRNA Pathway Drugs Candidates
12. Key Players
12.1 QIAGEN
12.2 Sigma-Aldrich Corporation (A Subsidiary of Merck KGaA)
12.3 Thermo Fisher Scientific, Inc.
12.4 Agilent Technologies Inc.
12.5 Affymetrix
12.6 Integrated DNA Technologies
12.7 Exiqon
12.8 Mirus Bio LLC
12.9 Wako Pure Chemical Industries
12.10 Rosetta Genomics Ltd.

List of Figures

Figure 5-1: Workflow of a miRNA Next-Generation Sequencing Experiment
Figure 6-1: Global – miRNA Market (Million US$), 2014-2020
Figure 6-2: Global – miRNA Tools Market (Million US$), 2014-2020
Figure 6-3: Global – miRNA Services Market (Million US$), 2014-2020
Figure 7-1: Global – miRNA Market by Applications (%), 2014
Figure 7-2: Number of miRNAs in the miRBase Database, (2002–2014)
Figure 7-3: Number of Registered miRNAs for Various Types of Cancers, (2015)
Figure 8-1: Global — miRNA Research Labs & Institutes Market (Million US$), 2014-2020
Figure 8-2: Global – miRNA Biotechnology Industry Market (Million US$), 2014–2020
Figure 8-3: Global – miRNA Hospitals & Diagnostic Center Market (Million US$), 2014-2020
Figure 9-1: The Americas – miRNA Market (Million US$), 2014-2020
Figure 9-2: The Americas – Ongoing miRNA Research by Country (%), 2015
Figure 9-3: The Americas – Ongoing miRNA Research by Disease (%), 2015
Figure 9-4: Europe – miRNA Market (Million US$), 2014-2020
Figure 9-5: Europe – Ongoing miRNA Research by Country (%), 2015
Figure 9-6: Europe – Ongoing miRNA Research by Disease (%), 2015
Figure 9-7: Asia Pacific – miRNA Market (Million US$), 2014-2020
Figure 9-8: Asia Pacific – Ongoing miRNA Research by Country (%), 2015
Figure 9-9: Asia Pacific – Ongoing miRNA Research by Disease (%), 2015
Figure 10-1: Global – miRNA Market by Application (%), 2014
Figure 10-2: Global – miRNA Cancer Market (Million US$), 2014-2020
Figure 10-3: Global – miRNA Neurological Diseases Market (Million US$), 2014-2020
Figure 10-4: Global – miRNA Cardiovascular Diseases Market (Million US$), 2014-2020
Figure 10-5: Global – miRNA Hepatic Diseases Market (Million US$), 2014-2020
Figure 10-6: Global – miRNA Other Diseases Market (Million US$), 2014-2020
Figure 11-1: Major miRNA Clinical Candidates

List of Tables:

Table 4-1: miRNA Purification Products by Supplier
Table 4-2: miRNA Labeling Products by Supplier
Table 4-3: miRNA Linear Amplification Products by Supplier
Table 4-4: miRNA Microarray Products by Supplier
Table 4-5: miRNA qRT-PCR Products by Supplier
Table 4-6: miRNA Inhibition Products by Supplier
Table 4-7: miRNA Transfection Products by Supplier
Table 5-1: Potential miRNAs for Therapeutic Application
Table 9-1: The Americas – miRNA Research (2005-September, 2015)
Table 9-2: Europe – miRNA Research (2005-September, 2015)
Table 9-3: Asia Pacific – miRNA Research (2005-September, 2015)
Table 10-1: miRNAs Associated with Common Human Diseases
Table 10-2: miRNAs Associated with Cancer
Table 10-3: miRNAs Associated with Cardiovascular Disorders
Table 10-4: miRNAs Associated with Hepatitis
Table 11-1: Major Players in miRNA Diagnostics & Therapeutics Applications
Table 12-1: Qiagen – miRNA Associated Product Line
Table 12-2: Sigma Aldrich – miRNA Associated Product Line
Table 12-3: Thermo Fisher – miRNA Associated Product Line
Table 12-4: Agilent – miRNA Associated Product Line
Table 12-5: Affymetrix – miRNA Associated Product Line
Table 12-6: IDT – miRNA Associated Product Line
Table 12-7: Exiqon – miRNA Associated Product Line
Table 12-8: Mirus Bio – miRNA Associated Product Line
Table 12-9: Wako – miRNA Associated Product Line
Table 12-10 Rosetta Genomics- miRNA Associated Product Line



【レポートのキーワード】

miRNA、遺伝子、miRNA技術

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ miRNAの世界市場(~2020)(Global miRNA Market Outlook to 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆